2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione as a cancer therapeutic
AssigneeMiddle Tennessee State University
InventorsYing GAO, Elliot ALTMAN
Life of this patent
Estimating the term…
Abstract
2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD), as well as variants, derivatives, analogs, modifications, and conjugates thereof, are identified as therapeutic agents for treating or preventing human cancers and precancerous conditions. DMDD can be isolated from the root of Averrhoa carambola L., commonly known as starfruit. Pharmaceutical and nutraceutical compositions, as well as dietary supplements, are provided, as are methods of administration and treatment.
Claims21
A method for treating or preventing cancer or a precancerous condition or inhibiting the growth of a tumor in a subject, the method comprising:
- administering to the subject a composition comprising an effective amount of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD), or variant, derivative or conjugate thereof.
(canceled)
14-18. (canceled)
A pharmaceutical composition comprising:
- 2-dodecyl-6-methoxycyclohexa-2, 5-diene-1,4-dione (DMDD), or variant, derivative or conjugate thereof;
- and
- a pharmaceutically acceptable carrier.
A dietary supplement or nutraceutical composition comprising 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD), or variant, derivative or conjugate thereof.
(canceled)
(canceled)
Dependencies are inferred from the claim text.